Matthew D. Dallas, VP, Finance at AVEO PHARMACEUTICALS INC (AVEO), sold 2,004 shares at $0.80 ($415) on 2015-01-07, disclosed to the SEC on 2015-01-08.
Scheduled sale ($415) by VP, Finance under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,485 | $0 | 0.0% |
| 2 | $0.80 | 519 | $415 | 100.0% |
| Total | $0.21 avg | 2,004 | $415 | 100% |
| Filing → |
| AVEO | SELL | 2015-01-20 | $3K | — | Filing → |